Hint | Answer | % Correct |
---|---|---|
Infections (Viral) | Herpes Simplex | 63%
|
Infections (Viral) | Herpes Zoster/Varicella | 63%
|
Scaling Disorders (Eczema) | Psoriasis | 59%
|
Malignant & Premalignant | Melanoma | 54%
|
Cosmetic | Acne | 52%
|
Malignant & Premalignant | Squamous Cell Carcinoma | 37%
|
Infections (Fungal) | Tinea - pedis, cruris, corporis, versicolor, capitis | 37%
|
Malignant & Premalignant | Basal Cell Carcinoma | 35%
|
Infections (Parasitic) | Scabies | 33%
|
Malignant & Premalignant | Actinic Keratosis | 24%
|
Infections (Bacterial) | Cellulitis | 24%
|
Infections (STDs) | Human Papilloma Virus | 22%
|
Infections (Bacterial) | Impetigo | 22%
|
Infections (STDs) | Syphillis | 22%
|
Scaling Disorders (Eczema) | Contact Dermatitis | 20%
|
Infections (Bacterial) | Lyme Disease | 17%
|
Bullous & Blistering | Pemphigus Vulgaris | 17%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Steven Johnson Syndrome | 17%
|
Scaling Disorders (Eczema) | Seborrheic Dermatitis | 15%
|
Bullous & Blistering | Bullous Pemphigoid | 13%
|
Infections (Bacterial) | Folliculitis, Furuncles and Carbuncles | 11%
|
Malignant & Premalignant | Seborrheic Keratosis | 11%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Toxic Epidermal Necrolysis | 11%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Urticaria | 9%
|
Infections (Bacterial) | Erysipelas | 7%
|
Infections (Bacterial) | Necrotizing Fascitis | 7%
|
Toxin | Staphylococcal Scalded Skin Syndrome | 7%
|
Scaling Disorders (Eczema) | Pityriasis Rosea | 4%
|
Scaling Disorders (Eczema) | Atopic Dermatits | 2%
|
Malignant & Premalignant | Benign Lesions | 2%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Fixed Drug Reaction | 2%
|
Malignant & Premalignant | Kaposi's Sarcoma | 2%
|
Infections (Parasitic) | Pediculosis | 2%
|
Bullous & Blistering | Pemphigus Foliaceus | 2%
|
Scaling Disorders (Eczema) | Stasis Dermatitis | 2%
|
Toxin | Toxic Shock Syndrome | 2%
|
Toxin | Anthrax | 0%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Erythema Nodusum | 0%
|
Bullous & Blistering (Drug Eruptions/Hypersensitivity) | Morbilliform Rash | 0%
|
Infections (Fungal) | Onychomychosis | 0%
|
Infections (Bacterial) | Paronychia | 0%
|
Bullous & Blistering | Porphyria Cutanea Tarda | 0%
|
Scaling Disorders (Eczema) | Xerosis (Asteatotic Dermstitis) | 0%
|